{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:44:47Z","timestamp":1788443087362,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["1I01BX003033"],"award-info":[{"award-number":["1I01BX003033"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NS83054"],"award-info":[{"award-number":["NS83054"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AG050431"],"award-info":[{"award-number":["AG050431"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s11064-018-02705-0","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T06:09:02Z","timestamp":1546668542000},"page":"751-762","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Cinnamic Acid Protects the Nigrostriatum in a Mouse Model of Parkinson\u2019s Disease via Peroxisome Proliferator-Activated Receptor\u03b1"],"prefix":"10.1007","volume":"44","author":[{"given":"Tim","family":"Prorok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malabendu","family":"Jana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6048-9598","authenticated-orcid":false,"given":"Kalipada","family":"Pahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","volume":"65","author":"TR Mhyre","year":"2012","unstructured":"Mhyre TR, Boyd JT, Hamill RW, Maguire-Zeiss KA (2012) Parkinson\u2019s disease. Subcell Biochem 65:389\u2013455","journal-title":"Subcell Biochem"},{"key":"2705_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature20411","volume":"539","author":"T Wyss-Coray","year":"2016","unstructured":"Wyss-Coray T (2016) Ageing, neurodegeneration and brain rejuvenation. Nature 539:180\u2013186","journal-title":"Nature"},{"key":"2705_CR3","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1474-4422(16)00116-2","volume":"15","author":"RB Postuma","year":"2016","unstructured":"Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, Olanow CW, Poewe W, Stern M (2016) The new definition and diagnostic criteria of Parkinson\u2019s disease. Lancet Neurol 15:546\u2013548","journal-title":"Lancet Neurol"},{"key":"2705_CR4","first-page":"375","volume":"5","author":"JA Opara","year":"2012","unstructured":"Opara JA, Brola W, Leonardi M, Blaszczyk B (2012) Quality of life in Parkinson\u2019s disease. J Med Life 5:375\u2013381","journal-title":"J Med Life"},{"key":"2705_CR5","doi-asserted-by":"publisher","first-page":"15011","DOI":"10.1038\/npjparkd.2015.11","volume":"1","author":"A Schrag","year":"2015","unstructured":"Schrag A, Choudhury M, Kaski D, Gallagher DA (2015) Why do patients with Parkinson\u2019s disease fall? A cross-sectional analysis of possible causes of falls. NPJ Parkinsons Dis 1:15011","journal-title":"NPJ Parkinsons Dis"},{"key":"2705_CR6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","volume":"5","author":"NJ Diederich","year":"2009","unstructured":"Diederich NJ, Fenelon G, Stebbins G, Goetz CG (2009) Hallucinations in Parkinson disease. Nat Rev Neurol 5:331\u2013342","journal-title":"Nat Rev Neurol"},{"key":"2705_CR7","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/ageing\/afp223","volume":"39","author":"JV Hindle","year":"2010","unstructured":"Hindle JV (2010) Ageing, neurodegeneration and Parkinson\u2019s disease. Age Ageing 39:156\u2013161","journal-title":"Age Ageing"},{"key":"2705_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/ana.410380407","volume":"38","author":"JP Seibyl","year":"1995","unstructured":"Seibyl JP, Marek KL, Quinlan D, Sheff K, Zoghbi S, Zea-Ponce Y, Baldwin RM, Fussell B, Smith EO, Charney DS, van Dyck C et al (1995) Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson\u2019s disease. Ann Neurol 38:589\u2013598","journal-title":"Ann Neurol"},{"key":"2705_CR9","doi-asserted-by":"publisher","first-page":"4247","DOI":"10.1016\/j.bmcl.2017.07.075","volume":"27","author":"JM Ellis","year":"2017","unstructured":"Ellis JM, Fell MJ (2017) Current approaches to the treatment of Parkinson\u2019s Disease. Bioorg Med Chem Lett 27:4247\u20134255","journal-title":"Bioorg Med Chem Lett"},{"key":"2705_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/mds.25292","volume":"28","author":"SL Kowal","year":"2013","unstructured":"Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A (2013) The current and projected economic burden of Parkinson\u2019s disease in the United States. Mov Disord 28:311\u2013318","journal-title":"Mov Disord"},{"key":"2705_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/nu9020163","volume":"9","author":"S Adisakwattana","year":"2017","unstructured":"Adisakwattana S (2017) Cinnamic acid and its derivatives: mechanisms for prevention and management of diabetes and its complications. Nutrients 9:163","journal-title":"Nutrients"},{"key":"2705_CR12","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/ijc.2910620319","volume":"62","author":"L Liu","year":"1995","unstructured":"Liu L, Hudgins WR, Shack S, Yin MQ, Samid D (1995) Cinnamic acid: a natural product with potential use in cancer intervention. Int J Cancer 62:345\u2013350","journal-title":"Int J Cancer"},{"key":"2705_CR13","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.3233\/JAD-2010-1331","volume":"19","author":"JP Guo","year":"2010","unstructured":"Guo JP, Yu S, McGeer PL (2010) Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer\u2019s disease therapy. J Alzheimers Dis 19:1359\u20131370","journal-title":"J Alzheimers Dis"},{"key":"2705_CR14","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4196\/kjpp.2018.22.3.257","volume":"22","author":"AA Hemmati","year":"2018","unstructured":"Hemmati AA, Alboghobeish S, Ahangarpour A (2018) Effects of cinnamic acid on memory deficits and brain oxidative stress in streptozotocin-induced diabetic mice. Korean J Physiol Pharmacol 22:257\u2013267","journal-title":"Korean J Physiol Pharmacol"},{"key":"2705_CR15","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","volume":"2","author":"V Jackson-Lewis","year":"2007","unstructured":"Jackson-Lewis V, Przedborski S (2007) Protocol for the MPTP mouse model of Parkinson\u2019s disease. Nat Protoc 2:141\u2013151","journal-title":"Nat Protoc"},{"key":"2705_CR16","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.4049\/jimmunol.1700149","volume":"198","author":"G Chandra","year":"2016","unstructured":"Chandra G, Roy A, Rangasamy SB, Pahan K (2016) Induction of adaptive immunity leads to nigrostriatal disease progression in MPTP mouse model of Parkinson\u2019s disease. J Immunol 198:4312\u20134326","journal-title":"J Immunol"},{"key":"2705_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11481-014-9552-2","volume":"9","author":"S Khasnavis","year":"2014","unstructured":"Khasnavis S, Pahan K (2014) Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neuroimmune Pharmacol 9:569\u2013581","journal-title":"J Neuroimmune Pharmacol"},{"key":"2705_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s11481-013-9503-3","volume":"9","author":"S Khasnavis","year":"2014","unstructured":"Khasnavis S, Roy A, Ghosh S, Watson R, Pahan K (2014) Protection of dopaminergic neurons in a mouse model of Parkinson\u2019s disease by a physically-modified saline containing charge-stabilized nanobubbles. J Neuroimmune Pharmacol 9:218\u2013232","journal-title":"J Neuroimmune Pharmacol"},{"key":"2705_CR19","doi-asserted-by":"publisher","first-page":"e96801","DOI":"10.1371\/journal.pone.0096801","volume":"9","author":"F Varghese","year":"2014","unstructured":"Varghese F, Bukhari AB, Malhotra R, De A (2014) IHC profiler: an open source plugin for the quantitative evaluation and automated scoring of immunohistochemistry images of human tissue samples. PLoS ONE 9:e96801","journal-title":"PLoS ONE"},{"key":"2705_CR20","doi-asserted-by":"publisher","first-page":"13543","DOI":"10.1523\/JNEUROSCI.4144-09.2009","volume":"29","author":"A Ghosh","year":"2009","unstructured":"Ghosh A, Roy A, Matras J, Brahmachari S, Gendelman HE, Pahan K (2009) Simvastatin inhibits the activation of p21ras and prevents the loss of dopaminergic neurons in a mouse model of Parkinson\u2019s disease. J Neurosci 29:13543\u201313556","journal-title":"J Neurosci"},{"key":"2705_CR21","doi-asserted-by":"publisher","first-page":"18754","DOI":"10.1073\/pnas.0704908104","volume":"104","author":"A Ghosh","year":"2007","unstructured":"Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K (2007) Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 104:18754\u201318759","journal-title":"Proc Natl Acad Sci USA"},{"key":"2705_CR22","doi-asserted-by":"publisher","first-page":"45984","DOI":"10.1074\/jbc.M200250200","volume":"277","author":"K Pahan","year":"2002","unstructured":"Pahan K, Jana M, Liu X, Taylor BS, Wood C, Fischer SM (2002) Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J Biol Chem 277:45984\u201345991","journal-title":"J Biol Chem"},{"key":"2705_CR23","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/nchembio.2204","volume":"12","author":"A Roy","year":"2016","unstructured":"Roy A, Kundu M, Jana M, Mishra RK, Yung Y, Luan CH, Gonzalez FJ, Pahan K (2016) Identification and characterization of PPARalpha ligands in the hippocampus. Nat Chem Biol 12:1075\u20131083","journal-title":"Nat Chem Biol"},{"key":"2705_CR24","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.physbeh.2009.04.021","volume":"98","author":"DW Luchtman","year":"2009","unstructured":"Luchtman DW, Shao D, Song C (2009) Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson\u2019s disease. Physiol Behav 98:130\u2013138","journal-title":"Physiol Behav"},{"key":"2705_CR25","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/08923970902785253","volume":"31","author":"A Roy","year":"2009","unstructured":"Roy A, Pahan K (2009) Gemfibrozil, stretching arms beyond lipid lowering. Immunopharmacol Immunotoxicol 31:339\u2013351","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"2705_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11481-014-9582-9","volume":"10","author":"A Roy","year":"2015","unstructured":"Roy A, Pahan K (2015) PPARalpha signaling in the hippocampus: crosstalk between fat and memory. J Neuroimmune Pharmacol 10:30\u201334","journal-title":"J Neuroimmune Pharmacol"},{"key":"2705_CR27","doi-asserted-by":"publisher","first-page":"8445","DOI":"10.1073\/pnas.1504890112","volume":"112","author":"GT Corbett","year":"2015","unstructured":"Corbett GT, Gonzalez FJ, Pahan K (2015) Activation of peroxisome proliferator-activated receptor alpha stimulates ADAM10-mediated proteolysis of APP. Proc Natl Acad Sci USA 112:8445\u20138450","journal-title":"Proc Natl Acad Sci USA"},{"key":"2705_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.phrs.2015.11.011","volume":"103","author":"A Ghosh","year":"2016","unstructured":"Ghosh A, Pahan K (2016) PPARalpha in lysosomal biogenesis: a perspective. Pharmacol Res 103:144\u2013148","journal-title":"Pharmacol Res"},{"key":"2705_CR29","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.celrep.2013.07.028","volume":"4","author":"A Roy","year":"2013","unstructured":"Roy A, Jana M, Corbett GT, Ramaswamy S, Kordower JH, Gonzalez FJ, Pahan K (2013) Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor alpha. Cell Rep 4:724\u2013737","journal-title":"Cell Rep"},{"key":"2705_CR30","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cmet.2015.05.022","volume":"22","author":"A Roy","year":"2015","unstructured":"Roy A, Jana M, Kundu M, Corbett GT, Rangaswamy SB, Mishra RK, Luan CH, Gonzalez FJ, Pahan K (2015) HMG-CoA reductase inhibitors bind to PPAR\u03b1 to upregulate neurotrophin expression in the brain and improve memory in mice. Cell Metab 22:253\u2013265","journal-title":"Cell Metab"},{"key":"2705_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1001\/archneur.56.5.529","volume":"56","author":"S Fahn","year":"1999","unstructured":"Fahn S (1999) Parkinson disease, the effect of levodopa, and the ELLDOPA trial. Earlier vs Later L-DOPA. Arch Neurol 56:529\u2013535","journal-title":"Arch Neurol"},{"key":"2705_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3389\/fnins.2016.00173","volume":"10","author":"P Hickey","year":"2016","unstructured":"Hickey P, Stacy M (2016) Deep brain stimulation: a paradigm shifting approach to treat Parkinson\u2019s disease. Front Neurosci 10:173","journal-title":"Front Neurosci"},{"key":"2705_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2018.06.031","author":"J Kwiatek-Majkusiak","year":"2018","unstructured":"Kwiatek-Majkusiak J, Geremek M, Koziorowski D, Tomasiuk R, Szlufik S, Friedman A (2018) Higher serum levels of pro-hepcidin in patients with Parkinson\u2019s disease treated with deep brain stimulation. Neurosci Lett. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2018.06.031","journal-title":"Neurosci Lett"},{"key":"2705_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40035-016-0058-0","volume":"5","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yang J, Shang H (2016) Meta-analysis of risk factors for Parkinson\u2019s disease dementia. Transl Neurodegener 5:11","journal-title":"Transl Neurodegener"},{"key":"2705_CR35","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2014.10.027","volume":"146","author":"K Curtin","year":"2015","unstructured":"Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015) Methamphetamine\/amphetamine abuse and risk of Parkinson\u2019s disease in Utah: a population-based assessment. Drug Alcohol Depend 146:30\u201338","journal-title":"Drug Alcohol Depend"},{"key":"2705_CR36","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/00001648-200009000-00007","volume":"11","author":"EJ Duell","year":"2000","unstructured":"Duell EJ, Millikan RC, Savitz DA, Newman B, Smith JC, Schell MJ, Sandler DP (2000) A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology 11:523\u2013531","journal-title":"Epidemiology"},{"key":"2705_CR37","first-page":"5932675","volume":"2017","author":"S Bohingamu Mudiyanselage","year":"2017","unstructured":"Bohingamu Mudiyanselage S, Watts JJ, Abimanyi-Ochom J, Lane L, Murphy AT, Morris ME, Iansek R (2017) Cost of living with Parkinson\u2019s disease over 12 months in Australia: a prospective cohort study. Parkinsons Dis 2017:5932675","journal-title":"Parkinsons Dis"},{"key":"2705_CR38","doi-asserted-by":"publisher","first-page":"e69105","DOI":"10.1371\/journal.pone.0069105","volume":"8","author":"VH Salvador","year":"2013","unstructured":"Salvador VH, Lima RB, dos Santos WD, Soares AR, Bohm PA, Marchiosi R, Ferrarese Mde L, Ferrarese-Filho O (2013) Cinnamic acid increases lignin production and inhibits soybean root growth. PLoS ONE 8:e69105","journal-title":"PLoS ONE"},{"key":"2705_CR39","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/0092-8674(95)90200-7","volume":"83","author":"DJ Mangelsdorf","year":"1995","unstructured":"Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841\u2013850","journal-title":"Cell"},{"key":"2705_CR40","doi-asserted-by":"publisher","first-page":"e87327","DOI":"10.1371\/journal.pone.0087327","volume":"9","author":"KR Dunning","year":"2014","unstructured":"Dunning KR, Anastasi MR, Zhang VJ, Russell DL, Robker RL (2014) Regulation of fatty acid oxidation in mouse cumulus-oocyte complexes during maturation and modulation by PPAR agonists. PLoS ONE 9:e87327","journal-title":"PLoS ONE"},{"key":"2705_CR41","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12015-008-9024-2","volume":"4","author":"A Cimini","year":"2008","unstructured":"Cimini A, Ceru MP (2008) Emerging roles of peroxisome proliferator-activated receptors (PPARs) in the regulation of neural stem cells proliferation and differentiation. Stem Cell Rev 4:293\u2013303","journal-title":"Stem Cell Rev"},{"key":"2705_CR42","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1038\/nature07202","volume":"454","author":"SJ Bensinger","year":"2008","unstructured":"Bensinger SJ, Tontonoz P (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature 454:470\u2013477","journal-title":"Nature"},{"key":"2705_CR43","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.it.2007.09.003","volume":"28","author":"DS Straus","year":"2007","unstructured":"Straus DS, Glass CK (2007) Anti-inflammatory actions of PPAR ligands: new insights on cellular and molecular mechanisms. Trends Immunol 28:551\u2013558","journal-title":"Trends Immunol"},{"key":"2705_CR44","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1046\/j.1471-4159.2003.02210.x","volume":"88","author":"T Dehmer","year":"2004","unstructured":"Dehmer T, Heneka MT, Sastre M, Dichgans J, Schulz JB (2004) Protection by pioglitazone in the MPTP model of Parkinson\u2019s disease correlates with I kappa B alpha induction and block of NF kappa B and iNOS activation. J Neurochem 88:494\u2013501","journal-title":"J Neurochem"},{"key":"2705_CR45","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1089\/152091503763816481","volume":"5","author":"DL Feinstein","year":"2003","unstructured":"Feinstein DL (2003) Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol Ther 5:67\u201373","journal-title":"Diabetes Technol Ther"},{"key":"2705_CR46","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbrc.2004.09.110","volume":"324","author":"T Toyama","year":"2004","unstructured":"Toyama T, Nakamura H, Harano Y, Yamauchi N, Morita A, Kirishima T, Minami M, Itoh Y, Okanoue T (2004) PPAR\u03b1 ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 324:697\u2013704","journal-title":"Biochem Biophys Res Commun"},{"key":"2705_CR47","doi-asserted-by":"publisher","DOI":"10.1155\/2008\/546753","author":"Y Yang","year":"2008","unstructured":"Yang Y, Gocke AR, Lovett-Racke A, Drew PD, Racke MK (2008) PPAR alpha regulation of the immune response and autoimmune encephalomyelitis. PPAR Res. \n                    https:\/\/doi.org\/10.1155\/2008\/546753","journal-title":"PPAR Res"},{"key":"2705_CR48","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.ejim.2005.04.012","volume":"16","author":"A Skoczynska","year":"2005","unstructured":"Skoczynska A, Dobosz T, Poreba R, Turczyn B, Derkacz A, Zoledziewska M, Jonkisz A, Lebioda A (2005) The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis. Eur J Intern Med 16:501\u2013506","journal-title":"Eur J Intern Med"},{"key":"2705_CR49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","volume":"3","author":"V Dias","year":"2013","unstructured":"Dias V, Junn E, Mouradian MM (2013) The role of oxidative stress in Parkinson\u2019s disease. J Parkinsons Dis 3:461\u2013491","journal-title":"J Parkinsons Dis"},{"key":"2705_CR50","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4330\/wjc.v5.i6.164","volume":"5","author":"T Kim","year":"2013","unstructured":"Kim T, Yang Q (2013) Peroxisome-proliferator-activated receptors regulate redox signaling in the cardiovascular system. World J Cardiol 5:164\u2013174","journal-title":"World J Cardiol"},{"key":"2705_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5607\/en.2013.22.1.11","volume":"22","author":"O Hwang","year":"2013","unstructured":"Hwang O (2013) Role of oxidative stress in Parkinson\u2019s disease. Exp Neurobiol 22:11\u201317","journal-title":"Exp Neurobiol"},{"key":"2705_CR52","first-page":"91","volume":"9","author":"J Blesa","year":"2015","unstructured":"Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson\u2019s disease. Front Neuroanat 9:91","journal-title":"Front Neuroanat"},{"key":"2705_CR53","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnana.2014.00080","volume":"8","author":"M Rodriguez","year":"2014","unstructured":"Rodriguez M, Morales I, Rodriguez-Sabate C, Sanchez A, Castro R, Brito JM, Sabate M (2014) The degeneration and replacement of dopamine cells in Parkinson\u2019s disease: the role of aging. Front Neuroanat 8:80","journal-title":"Front Neuroanat"},{"key":"2705_CR54","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1111\/j.1471-4159.2007.04807.x","volume":"103","author":"A Bento-Abreu","year":"2007","unstructured":"Bento-Abreu A, Tabernero A, Medina JM (2007) Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons. J Neurochem 103:871\u2013881","journal-title":"J Neurochem"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-02705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-018-02705-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-018-02705-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T13:43:37Z","timestamp":1589723017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-018-02705-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1007\/s11064-018-02705-0","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}